Antimyoclonic effect of levetiracetam in MERRF syndrome
- 1 April 2006
- journal article
- case report
- Published by Elsevier BV in Journal of the Neurological Sciences
- Vol. 243 (1-2), 97-99
- https://doi.org/10.1016/j.jns.2005.11.021
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Progressive myoclonic epilepsies: a review of genetic and therapeutic aspectsThe Lancet Neurology, 2005
- Limited efficacy of levetiracetam on myoclonus of different etiologiesParkinsonism & Related Disorders, 2005
- A novel mitochondrial tRNA Phe mutation causes MERRF syndromeNeurology, 2004
- Antimyoclonic Effect of Levetiracetam in 13 Patients with Unverricht–Lundborg Disease: Clinical ObservationsEpilepsia, 2004
- Mitochondrial Encephalomyopathies: Therapeutic ApproachAnnals of the New York Academy of Sciences, 2004
- Levetiracetam in progressive myoclonic epilepsyNeurology, 2004